Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Filings indexed 1,118 across all filing types
Latest filing 2024-08-08 AGM Information
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Proceedings of the 61st Annual General Meeting' and details the events and discussions that took place during the AGM held on 8th August 2024. It includes information about the meeting format (video conference), attendance of directors and auditors, the presentation of financial statements for the year ended 31st March 2024, resolutions considered, and voting procedures. The document is a detailed account of the AGM proceedings rather than the financial statements or reports themselves. It does not contain the full annual report or financial data but rather the minutes and summary of the AGM meeting. Therefore, it fits the category of AGM Information (AGM-R).
2024-08-08 English
Voting Results & Scrutinizers'' report for AGM
Regulatory Filings
2024-08-08 English
AGM Proceedings
Regulatory Filings
2024-08-08 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding a change in Key Managerial Personnel (KMP) authorized for determining and disclosing material events. It references Regulation 30 of the Listing Regulations, which pertains to disclosure of material events and changes in management personnel. The content is focused on management contact details and does not contain financial data, audit information, or report content. It is an announcement about management changes rather than a full management report or financial filing. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2024-08-08 English
KMP for determining & disclosing material events
Regulatory Filings
2024-08-08 English
Outcome of Board Meeting
Regulatory Filings
2024-08-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.